4.1 Review

Telomerase and idiopathic pulmonary fibrosis

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.mrfmmm.2011.10.013

Keywords

Dyskeratosis congenita; Interstitial lung disease; Aplastic anemia; Liver cirrhosis; Emphysema; Diabetes

Funding

  1. United States National Institutes of Health
  2. Maryland Stem Cell Research Foundation
  3. Flight Attendants Medical Research Institute

Ask authors/readers for more resources

Idiopathic pulmonary fibrosis (IPF) is the most common manifestation of telomere-mediated disorders. Germline mutations in the essential telomerase genes, hTERT and hTR, are the causal genetic defect in up to one-sixth of pulmonary fibrosis families. The presence of telomerase mutations in this subset is significant for clinical decisions as affected individuals can develop extra-pulmonary complications related to telomere shortening such as bone marrow failure and cryptogenic liver cirrhosis. There is also evidence that IPF is an ancestral manifestation of autosomal dominant telomere syndromes where, with successive generations, the disease evolves from pulmonary fibrosis into a bone marrow failure-predominant disorder, defining a unique form of genetic anticipation. Here I review the significance of telomere defects for understanding the genetics, disease patterns and pathophysiology of IPF. The importance of this diagnosis for patient care decisions will also be discussed. (C) 2011 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available